IRIS Accounts Production v25.2.0.378 05636153 director 1.1.24 31.12.24 31.12.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh056361532023-12-31056361532024-12-31056361532024-01-012024-12-31056361532022-12-31056361532023-01-012023-12-31056361532023-12-3105636153ns15:EnglandWales2024-01-012024-12-3105636153ns14:PoundSterling2024-01-012024-12-3105636153ns10:Director12024-01-012024-12-3105636153ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3105636153ns10:SmallEntities2024-01-012024-12-3105636153ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3105636153ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3105636153ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3105636153ns10:FullAccounts2024-01-012024-12-310563615312024-01-012024-12-3105636153ns10:OrdinaryShareClass12024-01-012024-12-3105636153ns10:CompanySecretary12024-01-012024-12-3105636153ns10:RegisteredOffice2024-01-012024-12-3105636153ns5:CurrentFinancialInstruments2024-12-3105636153ns5:CurrentFinancialInstruments2023-12-3105636153ns5:Non-currentFinancialInstruments2024-12-3105636153ns5:Non-currentFinancialInstruments2023-12-3105636153ns5:ShareCapital2024-12-3105636153ns5:ShareCapital2023-12-3105636153ns5:RetainedEarningsAccumulatedLosses2024-12-3105636153ns5:NetGoodwill2024-01-012024-12-3105636153ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3105636153ns5:PlantMachinery2024-01-012024-12-3105636153ns5:FurnitureFittings2024-01-012024-12-3105636153ns5:ComputerEquipment2024-01-012024-12-3105636153ns5:NetGoodwill2023-12-3105636153ns5:NetGoodwill2024-12-3105636153ns5:NetGoodwill2023-12-3105636153ns5:PlantMachinery2023-12-3105636153ns5:FurnitureFittings2023-12-3105636153ns5:ComputerEquipment2023-12-3105636153ns5:PlantMachinery2024-12-3105636153ns5:FurnitureFittings2024-12-3105636153ns5:ComputerEquipment2024-12-3105636153ns5:PlantMachinery2023-12-3105636153ns5:FurnitureFittings2023-12-3105636153ns5:ComputerEquipment2023-12-3105636153ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3105636153ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3105636153ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 05636153 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST DECEMBER 2024

FOR

VISION SURGERY & RESEARCH CENTRE
LIMITED

VISION SURGERY & RESEARCH CENTRE
LIMITED (REGISTERED NUMBER: 05636153)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024




Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 6


VISION SURGERY & RESEARCH CENTRE
LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST DECEMBER 2024







DIRECTOR: M V Pande





SECRETARY: N M Pande





REGISTERED OFFICE: 11 Ferriby High Road
North Ferriby
East Yorkshire
HU14 3LD





REGISTERED NUMBER: 05636153 (England and Wales)





ACCOUNTANTS: Cheetham Allen
Chartered Accountants
17 Wright Street
Hull
East Yorkshire
HU2 8HU

VISION SURGERY & RESEARCH CENTRE
LIMITED (REGISTERED NUMBER: 05636153)

BALANCE SHEET
31ST DECEMBER 2024

2024 2023
as restated
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 7,215 9,321
7,215 9,321

CURRENT ASSETS
Debtors 6 80,010 185
Cash at bank 566,902 707,454
646,912 707,639
CREDITORS
Amounts falling due within one year 7 24,250 20,513
NET CURRENT ASSETS 622,662 687,126
TOTAL ASSETS LESS CURRENT
LIABILITIES

629,877

696,447

CREDITORS
Amounts falling due after more than one
year

8

4,534

15,067
NET ASSETS 625,343 681,380

CAPITAL AND RESERVES
Called up share capital 9 1 1
Retained earnings 625,342 681,379
SHAREHOLDERS' FUNDS 625,343 681,380

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

VISION SURGERY & RESEARCH CENTRE
LIMITED (REGISTERED NUMBER: 05636153)

BALANCE SHEET - continued
31ST DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 1st September 2025 and were signed by:





M V Pande - Director


VISION SURGERY & RESEARCH CENTRE
LIMITED (REGISTERED NUMBER: 05636153)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

1. STATUTORY INFORMATION

Vision Surgery & Research Centre Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover represents the gross amount receivable for services provided.

GOODWILL
Goodwill, being the amount paid in connection with the acquisition of a business in 2008, is being amortised evenly over its estimated useful life of ten years.

INTANGIBLE ASSETS
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Consulting room equipment - 15% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% on reducing balance

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 3 ) .

VISION SURGERY & RESEARCH CENTRE
LIMITED (REGISTERED NUMBER: 05636153)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2024

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1st January 2024
and 31st December 2024 750,000
AMORTISATION
At 1st January 2024
and 31st December 2024 750,000
NET BOOK VALUE
At 31st December 2024 -
At 31st December 2023 -

5. TANGIBLE FIXED ASSETS
Consulting Fixtures
room and Computer
equipment fittings equipment Totals
£    £    £    £   
COST
At 1st January 2024 10,000 37,904 41,011 88,915
Additions - - 1,592 1,592
Disposals (10,000 ) - (17,258 ) (27,258 )
At 31st December 2024 - 37,904 25,345 63,249
DEPRECIATION
At 1st January 2024 9,257 32,522 37,815 79,594
Charge for year - 1,346 1,442 2,788
Eliminated on disposal (9,257 ) - (17,091 ) (26,348 )
At 31st December 2024 - 33,868 22,166 56,034
NET BOOK VALUE
At 31st December 2024 - 4,036 3,179 7,215
At 31st December 2023 743 5,382 3,196 9,321

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Amounts due from related company 80,010 -
Prepayments and accrued income - 185
80,010 185

VISION SURGERY & RESEARCH CENTRE
LIMITED (REGISTERED NUMBER: 05636153)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Bank loans and overdrafts 10,250 9,850
Taxation and social security 938 924
Other creditors 13,062 9,739
24,250 20,513

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
as restated
£    £   
Bank loan 4,534 15,067

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: as restated
£    £   
1 Ordinary £1 1 1